Rituximab in combination with high-dose dexamethasone for the treatment of relapsed/refractory chronic lymphocytic leukemia

Abstract

The article brings data on efficacy and safety of rituximab plus high-dose dexamethasone in the treatment of relapsed/refractory chronic lymphocytic leukemia.

Keywords

• chronic lymphocytic leukemia
• rituximab
• dexamethasone
• refractory disease
• chemoimmunotherapy corticosteroids